Hydrofarm shares plunge on $242M loss, debt default
Controlled agriculture equipment maker defaulted on $2.8M interest payment as oversupply crushes revenue
Hydrofarm Holdings Group shares plummeted on Friday after the controlled environment agriculture equipment manufacturer reported a catastrophic fourth-quarter loss and revealed it had defaulted on its debt obligations.
The Pennsylvania-based company posted a net loss of $242.2 million for the quarter ended December 31, 2025, including a non-cash impairment charge of $232.2 million primarily related to intangible assets. That compares with a net loss of $17.5 million in the same period a year earlier.
The earnings disaster was far worse than Wall Street expected. Hydrofarm reported a per-share loss of $51.89, missing analyst estimates of a $3.09 loss by more than 1,500 percent. Revenue fell 32.7 percent to $25.1 million, well short of the $35.7 million forecast.
Perhaps most troubling for investors, Hydrofarm disclosed that it had entered into default on its borrowing facilities. On February 4, 2026, the company deferred an interest payment of approximately $2.8 million on its senior secured term loan, triggering an event of default. The loan, which carried a principal balance of $114.4 million as of December 31, 2025, was reclassified as current debt, and interest now accrues at a rate 2 percent per annum above the original terms.
On February 17, the company terminated its revolving credit facility, eliminating a key source of working capital. Hydrofarm ended the year with just $6.3 million in cash.
"The company and its board of directors are exploring strategic alternatives to strengthen the company's liquidity and capital structure," Hydrofarm said in the earnings release, noting that it is engaged in ongoing discussions with term loan lenders.
The financial collapse reflects a brutal downturn in the controlled environment agriculture sector, particularly within the cannabis market. Hydrofarm cited industry oversupply as driving a 27.3 percent decline in product volume during the quarter. The company has been grappling with these challenges for more than a year, with Chief Executive Officer Tanya Der commenting on previous calls about consolidation among retail customers and slow government progress on cannabis rescheduling.
Hydrofarm's struggles have decimated its stock price, which has fallen more than 75 percent from its 52-week high of $4.78. Shares were trading around $1.06 on Friday, giving the company a market capitalization of roughly $8.5 million. The company implemented a 1-for-10 reverse stock split in February 2025 to maintain compliance with Nasdaq's minimum bid price requirement.
The company reported full-year 2025 revenue of $134.3 million, with a net loss of $290 million. The massive impairment charges suggest management has been forced to write down the value of acquisitions made during more optimistic times for the indoor farming sector.
Hydrofarm said it is pursuing operational changes including facility consolidation, headcount reduction, and focusing sales efforts on proprietary brand offerings to improve margins. However, with limited cash, mounting debt obligations, and a deteriorating market, investors are increasingly concerned about the company's ability to continue as a going concern.